Bernard Hirschel
Discontinuation of enfuvirtide in heavily pretreated HIV-infected individuals
Elzi L, Battegay M, Bernasconi E, Vernazza P, Hirschel B, Cavassini M, Fux C, Weber R, Kaufmann G, Swiss HIV Cohort Study. Discontinuation of enfuvirtide in heavily pretreated HIV-infected individuals. HIV clinical trials 2009; 10:207-14.
01.01.2009Discontinuation of enfuvirtide in heavily pretreated HIV-infected individuals
01.01.2009HIV clinical trials 2009; 10:207-14
Elzi Luigia, Battegay Manuel, Bernasconi Enos, Vernazza Pietro, Hirschel Bernard, Cavassini Matthias, Fux Christoph A, Weber Rainer, Kaufmann Gilbert, Swiss HIV Cohort Study
Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV
Young J, Battegay M, Bernasconi E, Vernazza P, Cavassini M, Hirschel B, Fux C, Rickenbach M, Guenthard H, Bucher H, Swiss HIV Cohort Study. Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV. Antiviral therapy 2009; 14:771-9.
01.01.2009Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV
01.01.2009Antiviral therapy 2009; 14:771-9
Young Jim, Battegay Manuel, Bernasconi Enos, Vernazza Pietro, Cavassini Matthias, Hirschel Bernard, Fux Christoph A, Rickenbach Martin, Guenthard Huldrych F, Bucher Heiner C, Swiss HIV Cohort Study
Impact of previous virological treatment failures and adherence on the outcome of antiretroviral therapy in 2007
Ballif M, Weber R, Opravil M, Rickenbach M, Furrer H, Hirschel B, Schmid P, Bernasconi E, Cavassini M, Battegay M, Ledergerber B, Swiss HIV Cohort Study. Impact of previous virological treatment failures and adherence on the outcome of antiretroviral therapy in 2007. PloS one 2009; 4:e8275.
01.01.2009Impact of previous virological treatment failures and adherence on the outcome of antiretroviral therapy in 2007
01.01.2009PloS one 2009; 4:e8275
Ballif Marie, Weber Rainer, Opravil Milos, Rickenbach Martin, Furrer Hansjakob, Hirschel Bernard, Schmid Patrick, Bernasconi Enos, Cavassini Matthias, Battegay Manuel, Ledergerber Bruno, Swiss HIV Cohort Study
HIV transmission under highly active antiretroviral therapy
Vernazza P, Hirschel B, Bernasconi E, Flepp M. HIV transmission under highly active antiretroviral therapy. Lancet 2008; 372:1806-7; author reply 1807.
22.11.2008HIV transmission under highly active antiretroviral therapy
22.11.2008Lancet 2008; 372:1806-7; author reply 1807
Vernazza Pietro, Hirschel Bernard, Bernasconi Enos, Flepp Markus
Antiretroviral treatment during pregnancy
Keiser O, Swiss HIV Cohort Study (SHCS), de Tejada B, Hirschel B, Drack G, Wunder D, Gremlich E, Brinkhof M, Rudin C, Gayet-Ageron A, Swiss Mother & Child HIV Cohort Study (MoCHiV). Antiretroviral treatment during pregnancy. AIDS (London, England) 2008; 22:2323-30.
12.11.2008Antiretroviral treatment during pregnancy
12.11.2008AIDS (London, England) 2008; 22:2323-30
Keiser Olivia, Swiss HIV Cohort Study (SHCS), de Tejada Begoña Martinez, Hirschel Bernard, Drack Gero, Wunder Dorothea, Gremlich Erika, Brinkhof Martin W G, Rudin Christoph, Gayet-Ageron Angèle, Swiss Mother & Child HIV Cohort Study (MoCHiV)
CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy
Khanna N, Kaufmann G, Battegay M, Hirschel B, Weber R, Bernasconi E, Vernazza P, Cavassini M, Furrer H, Opravil M, Swiss HIV Cohort Study. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008; 47:1093-101.
15.10.2008CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy
15.10.2008Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008; 47:1093-101
Khanna Nina, Kaufmann Gilbert R, Battegay Manuel, Hirschel Bernard, Weber Rainer, Bernasconi Enos, Vernazza Pietro, Cavassini Matthias, Furrer Hansjakob, Opravil Milos, Swiss HIV Cohort Study
Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort Study
Vo T, Weber R, Vernazza P, Bernasconi E, Cavassini M, Battegay M, Furrer H, Hirschel B, Keiser O, Ledergerber B, Swiss HIV Cohort Study. Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort Study. The Journal of infectious diseases 2008; 197:1685-94.
15.06.2008Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort Study
15.06.2008The Journal of infectious diseases 2008; 197:1685-94
Vo Thi Tuyet Nhung, Weber Rainer, Vernazza Pietro, Bernasconi Enos, Cavassini Matthias, Battegay Manuel, Furrer Hansjakob, Hirschel Bernard, Keiser Olivia, Ledergerber Bruno, Swiss HIV Cohort Study
Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era
El Amari E, Hirschel B, Bernasconi E, Hirsch H, Vernazza P, Cavassini M, Furrer H, Mueller N, Erb P, Steffen I, Cathomas G, Baumann M, Gayet-Ageron A, Toutous-Trellu L, Swiss HIV Cohort Study. Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era. AIDS (London, England) 2008; 22:1019-28.
31.05.2008Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era
31.05.2008AIDS (London, England) 2008; 22:1019-28
El Amari Emmanuelle Boffi, Hirschel Bernard, Bernasconi Enos, Hirsch Hans H, Vernazza Pietro, Cavassini Matthias, Furrer Hansjakob, Mueller Nicolas J, Erb Peter, Steffen Ingrid, Cathomas Gieri, Baumann Michele, Gayet-Ageron Angèle, Toutous-Trellu Laurence, Swiss HIV Cohort Study
Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir
von Wyl V, Günthard H, Ledergerber B, Rickenbach M, Vernazza P, Hirschel B, Furrer H, Cavassini M, Bernasconi E, Battegay M, Klimkait T, Bürgisser P, Böni J, Yerly S, Swiss HIV Cohort Study. Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008; 46:1299-309.
15.04.2008Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir
15.04.2008Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008; 46:1299-309
von Wyl Viktor, Günthard Huldrych F, Ledergerber Bruno, Rickenbach Martin, Vernazza Pietro, Hirschel Bernard, Furrer Hansjakob, Cavassini Matthias, Bernasconi Enos, Battegay Manuel, Klimkait Thomas, Bürgisser Philippe, Böni Jürg, Yerly Sabine, Swiss HIV Cohort Study
Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients
Glass T, Bucher H, Weber R, Rickenboch M, Bernasconi E, Vernazza P, Covassini M, Furrer H, Battegay M, Hirschel B, De Geest S, Swiss HIV Cohort Study. Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients. Antiviral therapy 2008; 13:77-85.
01.01.2008Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients
01.01.2008Antiviral therapy 2008; 13:77-85
Glass Tracy R, Bucher Heiner C, Weber Rainer, Rickenboch Martin, Bernasconi Enos, Vernazza Pietro, Covassini Matthias, Furrer Hansjakob, Battegay Manuel, Hirschel Bernard, De Geest Sabina, Swiss HIV Cohort Study
HIV transmission hunting--the chase for low risk events
Vernazza P, Hirschel B. HIV transmission hunting--the chase for low risk events. Antiviral therapy 2008; 13:641-2.
01.01.2008HIV transmission hunting--the chase for low risk events
01.01.2008Antiviral therapy 2008; 13:641-2
Vernazza Pietro, Hirschel Bernard
Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study
Fux C, Furrer H, Elzi L, Bernasconi E, Cavassini M, Vernazza P, Opravil M, Hirschel B, Bucher H, Simcock M, Rauch A, Swiss HIV Cohort Study. Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study. Antiviral therapy 2008; 13:1077-82.
01.01.2008Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study
01.01.2008Antiviral therapy 2008; 13:1077-82
Fux Christoph A, Furrer Hansjakob, Elzi Luigia, Bernasconi Enos, Cavassini Matthias, Vernazza Pietro, Opravil Milos, Hirschel Bernard, Bucher Heiner C, Simcock Mathew, Rauch Andri, Swiss HIV Cohort Study
Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study
Wolbers M, Bucher H, Günthard H, Yerly S, Battegay M, Bernasconi E, Vernazza P, Cavassini M, Furrer H, Hirschel B, von Wyl V, Opravil M, Swiss HIV Cohort Study. Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study. AIDS (London, England) 2007; 21:2201-7.
18.10.2007Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study
18.10.2007AIDS (London, England) 2007; 21:2201-7
Wolbers Marcel, Bucher Heiner C, Günthard Huldrych, Yerly Sabine, Battegay Manuel, Bernasconi Enos, Vernazza Pietro, Cavassini Matthias, Furrer Hansjakob, Hirschel Bernard, von Wyl Viktor, Opravil Milos, Swiss HIV Cohort Study
Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types
von Wyl V, Günthard H, Ledergerber B, Perrin L, Rickenbach M, Bernasconi E, Vernazza P, Hirschel B, Telenti A, Furrer H, Battegay M, Klimkait T, Bürgisser P, Böni J, Yerly S, for the Swiss HIV Cohort Study. Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types. Archives of internal medicine 2007; 167:1782-90.
10.09.2007Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types
10.09.2007Archives of internal medicine 2007; 167:1782-90
von Wyl Viktor, Günthard Huldrych F, Ledergerber Bruno, Perrin Luc, Rickenbach Martin, Bernasconi Enos, Vernazza Pietro, Hirschel Bernard, Telenti Amalio, Furrer Hansjakob, Battegay Manuel, Klimkait Thomas, Bürgisser Philippe, Böni Jürg, Yerly Sabine, for the Swiss HIV Cohort Study
Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy
Arnedo M, Tarr P, Telenti A, Beckmann J, Bergmann S, Darioli R, Bernasconi E, Vernazza P, Weber R, Elzi L, Hirschel B, Furrer H, Sahli R, Taffé P, Swiss HIV Cohort Study. Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy. Pharmacogenetics and genomics 2007; 17:755-64.
01.09.2007Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy
01.09.2007Pharmacogenetics and genomics 2007; 17:755-64
Arnedo Mireia, Tarr Philip E, Telenti Amalio, Beckmann Jacques S, Bergmann Sven, Darioli Roger, Bernasconi Enos, Vernazza Pietro, Weber Rainer, Elzi Luigia, Hirschel Bernard, Furrer Hansjakob, Sahli Roland, Taffé Patrick, Swiss HIV Cohort Study
Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study
Ledergerber B, Weber R, Egger M, Schmid P, Bernasconi E, Cavassini M, Hirschel B, Elzi L, Lehmann R, Rickenbach M, Furrer H, Swiss HIV Cohort Study. Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007; 45:111-9.
01.07.2007Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study
01.07.2007Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007; 45:111-9
Ledergerber Bruno, Weber Rainer, Egger Matthias, Schmid Patrick, Bernasconi Enos, Cavassini Matthias, Hirschel Bernard, Elzi Luigia, Lehmann Roger, Rickenbach Martin, Furrer Hansjakob, Swiss HIV Cohort Study
The role of compartment penetration in PI-monotherapy: the Atazanavir-Ritonavir Monomaintenance (ATARITMO) Trial
Vernazza P, Daneel S, Schiffer V, Decosterd L, Fierz W, Klimkait T, Hoffmann M, Hirschel B. The role of compartment penetration in PI-monotherapy: the Atazanavir-Ritonavir Monomaintenance (ATARITMO) Trial. AIDS (London, England) 2007; 21:1309-15.
19.06.2007The role of compartment penetration in PI-monotherapy: the Atazanavir-Ritonavir Monomaintenance (ATARITMO) Trial
19.06.2007AIDS (London, England) 2007; 21:1309-15
Vernazza Pietro, Daneel Synove, Schiffer Véronique, Decosterd Laurent, Fierz Walter, Klimkait Thomas, Hoffmann Matthias, Hirschel Bernard
Ecological study of the predictors of successful management of dyslipidemia in HIV-infected patients on ART: the Swiss HIV Cohort Study
Glass T, Bucher H, Battegay M, Hirschel B, Cavassini M, Bernasconi E, Furrer H, Rickenbach M, Vernazza P, Weber R, Swiss HIV Cohort Study. Ecological study of the predictors of successful management of dyslipidemia in HIV-infected patients on ART: the Swiss HIV Cohort Study. HIV clinical trials 2007; 8:77-85.
01.03.2007Ecological study of the predictors of successful management of dyslipidemia in HIV-infected patients on ART: the Swiss HIV Cohort Study
01.03.2007HIV clinical trials 2007; 8:77-85
Glass Tracy R, Bucher Heiner C, Battegay Manuel, Hirschel Bernard, Cavassini Matthias, Bernasconi Enos, Furrer Hansjakob, Rickenbach Martin, Vernazza Pietro, Weber Rainer, Swiss HIV Cohort Study
CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy
Wolbers M, Bucher H, Kaufmann G, Bernasconi E, Vernazza P, Hasse B, Cavassini M, Furrer H, Hirschel B, Battegay M, Swiss HIV Cohort Study. CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy. Antiviral therapy 2007; 12:889-97.
01.01.2007CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy
01.01.2007Antiviral therapy 2007; 12:889-97
Wolbers Marcel, Bucher Heiner C, Kaufmann Gilbert, Bernasconi Enos, Vernazza Pietro, Hasse Barbara, Cavassini Matthias, Furrer Hansjakob, Hirschel Bernard, Battegay Manuel, Swiss HIV Cohort Study
Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study
Simcock M, Furrer H, Hirschel B, Vernazza P, Sendi P, Rickenbach M, Bucher H, Battegay M, Koller M, Moirandat-Rytz S, Terziroli B, Blasko M, Karrer U, Bertisch B, Pless M, Blumer L, Vora S, Robinson J, Bernasconi E, Swiss HIV Cohort Study. Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study. Antiviral therapy 2007; 12:931-9.
01.01.2007Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study
01.01.2007Antiviral therapy 2007; 12:931-9
Simcock Mathew, Furrer Hansjakob, Hirschel Bernard, Vernazza Pietro, Sendi Pedram, Rickenbach Martin, Bucher Heiner C, Battegay Manuel, Koller Michael T, Moirandat-Rytz Sophie, Terziroli Benedetta, Blasko Monika, Karrer Urs, Bertisch Barbara, Pless Miklos, Blumer Liisa, Vora Samir, Robinson James Owen, Bernasconi Enos, Swiss HIV Cohort Study